Agendia's Series E Round

Agendia raised a round of funding on September 07, 2009.

Agendia is a privately held, leading molecular diagnostics company that develops and markets FFPE-based genomic diagnostic products, which help support physicians with their complex treatment decision…

Articles about Agendia's Series E Round: